![2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide structure](/static/products/955/955900-72-8.png)
2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide
TL;DR: 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide (CAS 955900-72-8) is a chemical compound with molecular formula C25H26N4O and molecular weight 398.21 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide
Also Known As: 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide, [2-(2,5-dimethylphenyl)-3-methyl(4-quinolyl)]-N-[(1,3-dimethylpyrazol-4-yl)met hyl]carboxamide
| Molecular Formula | C25H26N4O |
|---|---|
| Molecular Weight | 398.21 g/mol |
| LogP | 4.79898 |
| Topological Polar Surface Area | 59.81 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Exact Mass | 398.21066 |
| Heavy Atoms | 30 |
| Complexity | 1269.8704 |
Chemical Identifiers
| CAS Number | 955900-72-8 |
|---|---|
| SMILES | CC1=CC(=C(C=C1)C)C2=NC3=CC=CC=C3C(=C2C)C(=O)NCC4=CN(N=C4C)C |
Product Overview
2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide (CAS 955900-72-8), with molecular formula C25H26N4O and molecular weight 398.21 g/mol. IUPAC: 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide.
Chemical Property Profile of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide
Property Insights of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide
The XLogP value of 4.79898 indicates that 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 59.81 Ų, 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide has 1 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide?
The CAS number of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide is 955900-72-8.
What is the molecular formula of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide?
The molecular formula of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide is C25H26N4O.
What is the molecular weight of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide?
The molecular weight of 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide is 398.21 g/mol.
Where can I buy 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide?
You can request a quote for 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide?
Yes, KEHONG BIO provides custom synthesis services for 2-(2,5-dimethylphenyl)-N-[(1,3-dimethylpyrazol-4-yl)methyl]-3-methylquinoline-4-carboxamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.